Vivos Therapeutics, Inc. (VVOS): Revenue
$17.44M
Year ended 2025-12-31
$20.90M
Trailing 12 months to 2026-06-30
+2.9%
3-year compound annual growth
+5.9%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $17.44M | +16.0% | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | $15.03M | +8.9% | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | $13.80M | -13.9% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $16.02M | -5.1% | 2024-07-30, From 2022-01-01 |
| 2021-12-31 | $16.89M | +29.2% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $13.07M | +14.7% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $11.39M | n/a | 2021-03-25, From 2019-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $17.44M | +16.0% |
| Nephros Inc (NEPH) | 2025-12-31 | $18.79M | +32.7% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $16.10M | +50.7% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $16.00M | +16.0% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 2026-03-31 | $19.53M | +36.7% |
| Spectral AI, Inc. (MDAI) | 2025-12-31 | $19.65M | -33.6% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $15.23M | -52.6% |
| DarioHealth Corp. (DRIO) | 2025-12-31 | $22.36M | -17.3% |
| Baird Medical Investment Holdings Ltd (BDMD) | 2025-12-31 | $22.54M | -39.2% |
Compare VVOS, NEPH, PROF, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗